Serina Therapeutics, Inc. Temporary Equity, Liquidation Preference
Serina Therapeutics, Inc. (SER) had Temporary Equity, Liquidation Preference of $0 as of 2024-12-31, per its 10-K filed 2025-03-24.
Financial Statements › Balance Sheet › Equity › Temporary Equity › Temporary Equity, Other Disclosure
us-gaap:TemporaryEquityLiquidationPreference · last filed 2025-03-24
- 2024-12-31: Temporary Equity, Liquidation Preference $0.00.
- 2024-09-30: Temporary Equity, Liquidation Preference $0.00.
- 2024-03-31: Temporary Equity, Liquidation Preference $36.40M.
- 2023-12-31: Temporary Equity, Liquidation Preference $36.98M; Temporary Equity, Liquidation Preference as first filed $36.40K.
| Period end | Temporary Equity, Liquidation Preference | Temporary Equity, Liquidation Preference as first filed |
|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-24 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 | |
| 2024-03-31 | $36.40M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $36.98M 10-K · filed 2025-03-24 | $36.40K 10-Q · filed 2024-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |